Holly Energy Partners, L.P. (HEP) Is At $30.06 Formed Wedge; Caspian Capital LP Has Lifted Tenet Healthcare (THC) Position By $6.40 Million

Holly Energy Partners, L.P. (HEP) formed wedge down with $28.56 target or 5.00% below today’s $30.06 share price. Holly Energy Partners, L.P. (HEP) has $3.16 billion valuation. The stock increased 3.05% or $0.89 during the last trading session, reaching $30.06. About 152,645 shares traded. Holly Energy Partners, L.P. (NYSE:HEP) has risen 4.19% since March 13, 2017 and is uptrending. It has underperformed by 12.51% the S&P500.

Caspian Capital Lp increased Tenet Healthcare Corp (THC) stake by 76.19% reported in 2017Q3 SEC filing. Caspian Capital Lp acquired 400,000 shares as Tenet Healthcare Corp (THC)’s stock declined 9.34%. The Caspian Capital Lp holds 925,000 shares with $15.20 million value, up from 525,000 last quarter. Tenet Healthcare Corp now has $2.49B valuation. The stock increased 2.03% or $0.49 during the last trading session, reaching $24.67. About 2.56M shares traded or 2.52% up from the average. Tenet Healthcare Corporation (NYSE:THC) has declined 36.81% since March 13, 2017 and is downtrending. It has underperformed by 53.51% the S&P500.

Among 23 analysts covering Tenet Healthcare Corporation (NYSE:THC), 9 have Buy rating, 4 Sell and 10 Hold. Therefore 39% are positive. Tenet Healthcare Corporation had 79 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Wednesday, May 4 by Citigroup. The firm has “Underperform” rating given on Monday, June 13 by Ladenburg Thalmann. As per Wednesday, February 28, the company rating was upgraded by Raymond James. The firm has “Hold” rating by RBC Capital Markets given on Monday, November 13. As per Wednesday, October 18, the company rating was maintained by Mizuho. The rating was maintained by RBC Capital Markets on Monday, July 17 with “Hold”. Credit Suisse maintained Tenet Healthcare Corporation (NYSE:THC) rating on Thursday, March 24. Credit Suisse has “Neutral” rating and $31 target. Mizuho upgraded the shares of THC in report on Tuesday, January 19 to “Buy” rating. Barclays Capital initiated the shares of THC in report on Thursday, September 10 with “Overweight” rating. The firm has “Neutral” rating by Mizuho given on Thursday, October 22.

Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.45, from 1.33 in 2017Q2. It dived, as 33 investors sold THC shares while 57 reduced holdings. 41 funds opened positions while 79 raised stakes. 122.38 million shares or 7.67% more from 113.66 million shares in 2017Q2 were reported. 240,000 were accumulated by Nomura. Swiss Bancorp stated it has 168,300 shares. Balyasny Asset Mngmt Ltd Limited Liability Company owns 1.45M shares for 0.09% of their portfolio. Raymond James Assoc reported 16,138 shares stake. Nj State Employees Deferred Compensation Plan has 0.25% invested in Tenet Healthcare Corporation (NYSE:THC) for 85,000 shares. North Tide Llc holds 1.53M shares. Meeder Asset Management invested in 0.09% or 51,774 shares. Morgan Stanley reported 355,047 shares. The New York-based Anchorage Gp Ltd Llc has invested 0.22% in Tenet Healthcare Corporation (NYSE:THC). Hsbc Public Limited Com has 0.01% invested in Tenet Healthcare Corporation (NYSE:THC) for 211,015 shares. Wolverine Asset Mngmt Ltd Liability Com reported 15,928 shares. Huber Mngmt Ltd Liability holds 0.32% of its portfolio in Tenet Healthcare Corporation (NYSE:THC) for 358,000 shares. Cwm Limited Co has 150 shares for 0% of their portfolio. Highland Management Limited Partnership stated it has 0.23% in Tenet Healthcare Corporation (NYSE:THC). Proxima Capital Limited Liability Corporation accumulated 200,000 shares.